- Report
- October 2024
- 188 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 158 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 193 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 200 Pages
United States
From €2364EUR$2,490USD£1,994GBP
- Report
- December 2023
- 300 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- November 2022
- 264 Pages
Global
From €2492EUR$2,625USD£2,102GBP
€4984EUR$5,250USD£4,204GBP
- Report
- October 2020
- 100 Pages
China
From €1889EUR$1,990USD£1,594GBP
- Report
- July 2023
- 111 Pages
Global
From €4272EUR$4,500USD£3,603GBP
Molecular Oncology is a sub-field of Molecular Diagnostics that focuses on the diagnosis and treatment of cancer. It involves the use of molecular techniques to identify and characterize cancer-causing genes, proteins, and other molecules. Molecular Oncology is used to detect and monitor cancer, as well as to develop targeted therapies. It is also used to identify biomarkers that can be used to predict the risk of cancer and to monitor the effectiveness of treatments.
Molecular Oncology is a rapidly growing field, with advances in technology and research leading to new and improved diagnostic and therapeutic options. Companies in the Molecular Oncology market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Qiagen, and Roche. Show Less Read more
